R M Donlan

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Biofilms: survival mechanisms of clinically relevant microorganisms
    Rodney M Donlan
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 15:167-93. 2002
  2. ncbi High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm
    Linda M Weigel
    NCID DHQP ELB MS G 08, Centers for Disease Control and Prevention, 1600 Clifton Road, N E, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 51:231-8. 2007
  3. ncbi Protocol for detection of biofilms on needleless connectors attached to central venous catheters
    R M Donlan
    Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 39:750-3. 2001
  4. ncbi Biofilms on central venous catheters: is eradication possible?
    R M Donlan
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Curr Top Microbiol Immunol 322:133-61. 2008
  5. ncbi Legionella pneumophila associated with the protozoan Hartmannella vermiformis in a model multi-species biofilm has reduced susceptibility to disinfectants
    R M Donlan
    Epidemiology and Laboratory Branch, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta 30333, USA
    Biofouling 21:1-7. 2005
  6. ncbi Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner
    Rodney M Donlan
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 52:1038-45. 2011
  7. ncbi Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time
    R M Donlan
    Biofilm Laboratory, ELB DHQP NCID, Centers for Disease Control and Prevention, Mail Stop C 16, 1600 Clifton Rd, N E, Atlanta, GA 30333, USA
    Appl Environ Microbiol 70:4980-8. 2004
  8. ncbi Biofilms: microbial life on surfaces
    Rodney M Donlan
    Biofilm Laboratory, Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:881-90. 2002
  9. ncbi Biofilms and device-associated infections
    R M Donlan
    Centers for Disease Control and Prevention Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:277-81. 2001
  10. ncbi Biofilm formation: a clinically relevant microbiological process
    R M Donlan
    Biofilm Laboratory, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:1387-92. 2001

Detail Information

Publications20

  1. ncbi Biofilms: survival mechanisms of clinically relevant microorganisms
    Rodney M Donlan
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 15:167-93. 2002
    ..In the future, treatments may be based on inhibition of genes involved in cell attachment and biofilm formation...
  2. ncbi High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm
    Linda M Weigel
    NCID DHQP ELB MS G 08, Centers for Disease Control and Prevention, 1600 Clifton Road, N E, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 51:231-8. 2007
    ..The potential for interspecies transfer of antimicrobial resistance genes, including resistance to vancomycin, may be enhanced by the microenvironment of a biofilm...
  3. ncbi Protocol for detection of biofilms on needleless connectors attached to central venous catheters
    R M Donlan
    Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 39:750-3. 2001
    ..Sixty-three percent of 24 NCs collected from a bone marrow transplant center contained biofilms comprised primarily of coagulase-negative staphylococci...
  4. ncbi Biofilms on central venous catheters: is eradication possible?
    R M Donlan
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Curr Top Microbiol Immunol 322:133-61. 2008
    ..Promising technologies that incorporate novel approaches such as ultrasound, bacteriophage, quorum-sensing inhibitors, or enzymes may also provide useful approaches in the future...
  5. ncbi Legionella pneumophila associated with the protozoan Hartmannella vermiformis in a model multi-species biofilm has reduced susceptibility to disinfectants
    R M Donlan
    Epidemiology and Laboratory Branch, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta 30333, USA
    Biofouling 21:1-7. 2005
    ..A similar pattern was observed for 15 and 60 min contact times. These results indicate that L. pneumophila was less susceptible to MCA or FRC when associated with biofilm-associated H. vermiformis in a model potable water biofilm...
  6. ncbi Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner
    Rodney M Donlan
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 52:1038-45. 2011
    ..These approaches have the potential to prevent or eradicate biofilms on indwelling intravascular catheters and prevent or resolve catheter-related infections...
  7. ncbi Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time
    R M Donlan
    Biofilm Laboratory, ELB DHQP NCID, Centers for Disease Control and Prevention, Mail Stop C 16, 1600 Clifton Rd, N E, Atlanta, GA 30333, USA
    Appl Environ Microbiol 70:4980-8. 2004
    ..pneumoniae over time by using multiple, corroborative techniques. This approach could prove useful for the study of biofilm processes of this or other microorganisms of clinical or industrial relevance...
  8. ncbi Biofilms: microbial life on surfaces
    Rodney M Donlan
    Biofilm Laboratory, Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:881-90. 2002
    ..A greater understanding of biofilm processes should lead to novel, effective control strategies for biofilm control and a resulting improvement in patient management...
  9. ncbi Biofilms and device-associated infections
    R M Donlan
    Centers for Disease Control and Prevention Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:277-81. 2001
    ....
  10. ncbi Biofilm formation: a clinically relevant microbiological process
    R M Donlan
    Biofilm Laboratory, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:1387-92. 2001
    ..An appreciation of the role of biofilms in infection should enhance the clinical decision-making process...
  11. ncbi Role of biofilms in the survival of Legionella pneumophila in a model potable-water system
    R Murga
    Epidemiology and Laboratory Branch, Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Microbiology 147:3121-6. 2001
    ..pneumophila cells present in the biofilm were monitored for 15 d, with and without the presence of H. vermiformis, and it was found that, although unable to replicate in the absence of H. vermiformis, L. pneumophila was able to persist...
  12. ncbi Biofilm formation by gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model
    R Murga
    Biofilm Research Laboratory, Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    J Clin Microbiol 39:2294-7. 2001
    ..Results suggest that a conditioning film of blood components promotes biofilm formation by these organisms in an in vitro system...
  13. ncbi Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system
    Weiling Fu
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop C 16, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 54:397-404. 2010
    ..These results suggest the potential of applying phages, especially phage cocktails, to the surfaces of indwelling medical devices for mitigating biofilm formation by clinically relevant bacteria...
  14. ncbi Chlorine inactivation of bacterial bioterrorism agents
    Laura J Rose
    Centers for Disease Control and Prevention, 1600 Clifton Rd, C16, Atlanta, GA 30333, USA
    Appl Environ Microbiol 71:566-8. 2005
    ..Water contaminated with spores of Bacillus anthracis spores would require further treatment...
  15. ncbi Preventing biofilms of clinically relevant organisms using bacteriophage
    Rodney M Donlan
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop C 16, 1600 Clifton Road, N E, Atlanta, GA 30333, USA
    Trends Microbiol 17:66-72. 2009
    ..Phage mixtures or engineered phages could provide effective strategies to overcome these obstacles. Lytic bacteriophages could become a new class of anti-biofilm agents...
  16. ncbi Structural analysis of biofilm formation by rapidly and slowly growing nontuberculous mycobacteria
    Margaret M Williams
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Appl Environ Microbiol 75:2091-8. 2009
    ..This indicates that M. avium is better adapted for growth in potable water systems than in laboratory incubation conditions and suggests some advantage that MAC has over RGM in low-nutrient environments...
  17. ncbi Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis
    John J Curtin
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop C-16, 1600 Clifton Road, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 50:1268-75. 2006
    ..epidermidis over a 24-h exposure period, suggesting the potential of bacteriophage for mitigating biofilm formation on indwelling catheters and reducing the incidence of catheter-related infections...
  18. ncbi Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska
    Henry C Baggett
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska 99508, USA
    J Infect Dis 189:1565-73. 2004
    ..001). The majority of MRSA isolates were closely related by PFGE. CONCLUSION: Selective antibiotic pressure for drug-resistant strains carrying PVL may have led to the emergence and spread of CO-MRSA in rural Alaska...
  19. ncbi Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm
    Steven L Percival
    Department of Microbiology, Leeds Teaching Hospitals, Leeds, United Kingdom
    Infect Control Hosp Epidemiol 26:515-9. 2005
    ..CONCLUSION: Antimicrobial lock treatment using 40 mg/mL(-1) of tetrasodium EDTA for at least 21 hours could significantly reduce or potentially eradicate CVC-associated biofilms of clinically relevant microorganisms...
  20. ncbi Statistical assessment of a laboratory method for growing biofilms
    Darla M Goeres
    Center for Biofilm Engineering, Montana State University, Bozeman, MT 59717-3980, USA
    Microbiology 151:757-62. 2005
    ..These results demonstrate that the CBR system is a reliable experimental tool for growing a standard biofilm in the laboratory and that it can be adapted to study several different micro-organisms...